Evidence map›Paper›PMID 33764297›Full record

ArticleeLife2021

Highly parallelized droplet cultivation and prioritization of antibiotic producers from natural microbial communities.

Lisa Mahler, Sarah P Niehs, Karin Martin, Thomas Weber, Kirstin Scherlach, Christian Hertweck, Martin Roth, Miriam A Rosenbaum

Abstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Precise loading of scarce reagents on droplet microarrays.bioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lisa MahlerBio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Jena, Germany.ORCID 0000-0002-8241-9782
Sarah P NiehsBiomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Jena, Germany.ORCID 0000-0002-2012-5949
Karin MartinBio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Jena, Germany.
Thomas WeberBio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Jena, Germany.ORCID 0000-0001-5048-0653
Kirstin ScherlachBiomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Jena, Germany.
Christian HertweckFaculty of Biological Sciences, Friedrich Schiller University, Jena, Germany.ORCID 0000-0002-0367-337X
Martin RothBio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Jena, Germany.
Miriam A RosenbaumBio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Jena, Germany.ORCID 0000-0002-4566-8624

Funding

Deutsche Forschungsgemeinschaft 239748522 - SFB 1127Deutsche Forschungsgemeinschaft GSC 214German Center for Infection Research TTU 09.811German Center for Infection Research DZIF TTU 09.811Thuringian Ministry of Economy, Labor and Technology 2014FE9037Thuringian Ministry of Economy, Labour and Technology 2014FE9037Thuringian Ministry of Education, Science and Culture 13008-715Thuringian Ministry of Eduction, Scienc and Culture 13008-715
6 · The paper itself

Abstract

Antibiotics from few culturable microorganisms have saved millions of lives since the 20th century. But with resistance formation, these compounds become increasingly ineffective, while the majority of microbial and with that chemical compound diversity remains inaccessible for cultivation and exploration. Culturing recalcitrant bacteria is a stochastic process. But conventional methods are limited to low throughput. By increasing (i) throughput and (ii) sensitivity by miniaturization, we innovate microbiological cultivation to comply with biological stochasticity. Here, we introduce a droplet-based microscale cultivation system, which is directly coupled to a high-throughput screening for antimicrobial activity prior to strain isolation. We demonstrate that highly parallelized in-droplet cultivation starting from single cells results in the cultivation of yet uncultured species and a significantly higher bacterial diversity than standard agar plate cultivation. Strains able to inhibit intact reporter strains were isolated from the system. A variety of antimicrobial compounds were detected for a selected potent antibiotic producer.

Indexed as

Anti-Infective AgentsBacteriaBacteriological TechniquesHigh-Throughput Screening AssaysMicrobiotaAnti-Infective Agentsantibioticsantimicrobial compoundhigh-throughput cultivationinfectious diseasemicrobiologystrain isolationuncultured microorganisms

Identifiers

PMID33764297
PMCPMC8081529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.